Page last updated: 2024-08-26

prolinedithiocarbamate and Lupus Erythematosus, Systemic

prolinedithiocarbamate has been researched along with Lupus Erythematosus, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, H; Chen, J; Geng, L; Hou, Y; Li, X; Lu, L; Shi, S; Sun, L; Tang, Y; Xie, H; Zeng, X	1

Trials

1 trial(s) available for prolinedithiocarbamate and Lupus Erythematosus, Systemic

Article	Year
Activated NF-κB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling. Stem cells and development, 2013, Feb-15, Volume: 22, Issue:4 Topics: Adult; Antineoplastic Agents; Bone Marrow Cells; Bone Morphogenetic Protein 2; Cell Differentiation; Cells, Cultured; Down-Regulation; Female; Humans; Lupus Erythematosus, Systemic; Male; Mesenchymal Stem Cells; Middle Aged; NF-kappa B; Osteoblasts; Osteogenesis; Phosphorylation; Proline; Signal Transduction; Smad Proteins; Thiocarbamates; Tumor Necrosis Factor-alpha	2013

Article

Year

Activated NF-κB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling.

Stem cells and development, 2013, Feb-15, Volume: 22, Issue:4

Topics: Adult; Antineoplastic Agents; Bone Marrow Cells; Bone Morphogenetic Protein 2; Cell Differentiation; Cells, Cultured; Down-Regulation; Female; Humans; Lupus Erythematosus, Systemic; Male; Mesenchymal Stem Cells; Middle Aged; NF-kappa B; Osteoblasts; Osteogenesis; Phosphorylation; Proline; Signal Transduction; Smad Proteins; Thiocarbamates; Tumor Necrosis Factor-alpha

2013